The biosimilar will launch in the United States in June 2025 as part of a global settlement with Amgen, which manufactures the reference product. The higher dosage of denosumab-bnht (Bomyntra ...

A settlement between Amgen and Fresenius Kabi will permit the biosimilar to launch in mid-2025 in the U.S. The FDA has approved two new denosumab biosimilars that are interchangeable with the ...

The German drugmaker said the Tyenne approval – its third for a biosimilar after Idacio (adalimumab) and Stimufend (pegfilgrastim) – is a key component of its Vision 2026 strategy aimed at ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.

You carry your phone on you all the time. Including your list of groceries on it makes sense rather than carrying around a second thing. Luckily, there is a boatload of options in this space.

The Company launched itsfirst biosimilar viz. Pegfilgrastim in Russia. It launched 30 new products in the US generics market. It commenced commercialmanufacturing from 2 more areas of Oral Solid ...

Sandoz signed a private label agreement with CVS subsidiary Cordavis, which works with manufacturers to commercialize biosimilars in the U.S. Hyrimoz was the first product to be included under the ...

CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...

Notable Awards or Recognitions:** * The text doesn't specifically list awards. * However, references to new products and technologies (e.g., 'most powerful Mac ever,' 'Apple Intelligence') suggest ...